Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Thrombocytopenia(ITP)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT03784898
What this trial is testing

Collection of Blood Samples From Patients With Relapsing MS Who Developed ITP After Receiving Lemtrada

Who this might be right for
Multiple Sclerosis
Genzyme, a Sanofi Company 13
Early research (Phase 1)Study completedNCT01437384
What this trial is testing

Pharmacokinetic and Pharmacodynamic Study in Healthy Subjects Comparing the Interactions Between E5501 and Verapamil and Cyclosporine.

Who this might be right for
Idiopathic Thrombocytopenic Purpura (ITP)
Eisai Inc. 36
Not applicableStudy completedNCT02063763
What this trial is testing

TPO-mimetics Before Splenectomy in Adult Primary Immune Thrombocytopenia Patients.

Who this might be right for
Adult PatientsImmune Primary ThrombocytopeniaSplenectomy+1 more
Gruppo Italiano Malattie EMatologiche dell'Adulto 31
Large-scale testing (Phase 3)Active Not RecruitingNCT04812925
What this trial is testing

Evaluate the Safety and Efficacy of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia
argenx 173
Large-scale testing (Phase 3)Study completedNCT01438840
What this trial is testing

Efficacy and Safety of Oral E5501 Plus Standard of Care for the Treatment of Thrombocytopenia in Adults With Chronic Immune Thrombocytopenia (Amendment 02)

Who this might be right for
Chronic ThrombocytopeniaImmune Thrombocytopenia
Eisai Inc. 49
Large-scale testing (Phase 3)Study completedNCT05566990
What this trial is testing

A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj.10% in Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
SK Plasma Co., Ltd. 34
Not applicableNot Yet RecruitingNCT07146555
What this trial is testing

Vitamin D Satus in Adults With Newly Diagnosed ITP

Who this might be right for
Vitamin D Concentration
Assiut University 84
Post-approval studies (Phase 4)Ended earlyNCT03866798
What this trial is testing

Study to Evaluate the Efficacy and Safety of PANZYGA in Pediatric Patients With Chronic Immune Thrombocytopenia (ITP)

Who this might be right for
Chronic Immune Thrombocytopenia
Octapharma 6
Large-scale testing (Phase 3)Study completedNCT05621330
What this trial is testing

Efficacy and Safety of QL0911 in Adult Patients With Chronic Primary Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia
Qilu Pharmaceutical Co., Ltd. 216
Not applicableEnded earlyNCT02050581
What this trial is testing

A Chart Review of Rituximab Plus Repeated Cycles of Dexamethasone

Who this might be right for
Idiopathic Thrombocytopenia Purpura
Weill Medical College of Cornell University 72
Large-scale testing (Phase 3)Study completedNCT01444417
What this trial is testing

Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients

Who this might be right for
Idiopathic Thrombocytopenic PurpuraThrombocytopeniaThrombocytopenia in Pediatric Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)+3 more
Amgen 62
Testing effectiveness (Phase 2)Study completedNCT01880047
What this trial is testing

Safety and Efficacy of Eltrombopag at Escalated Doses

Who this might be right for
Immune ThrombocytopeniaPlatelet Disorder
Weill Medical College of Cornell University 35
Not applicableUnknownNCT06466824
What this trial is testing

Observational Study on the Outcome of Patients With ITP Who Underwent Splenectomy After 2010

Who this might be right for
Primary Immune Thrombocytopenia
Gruppo Italiano Malattie EMatologiche dell'Adulto 157
Not applicableStudy completedNCT05095896
What this trial is testing

The Serum Lipid Profiles in ITP: a Retrospective Study

Who this might be right for
Immune Thrombocytopenia
Ming Hou 457
Not applicableLooking for participantsNCT04005638
What this trial is testing

Biological Bank for the Patients Followed in a Constitutive Reference Center for Autoimmune Cytopenia

Who this might be right for
Immune ThrombocytopeniaAutoimmune Hemolytic AnemiaAutoimmune Neutropenia
University Hospital, Bordeaux 200
Testing effectiveness (Phase 2)Looking for participantsNCT05214391
What this trial is testing

A Prospective, One-arm and Open Clinical Study of Zanubrutinib in the Treatment of Immune Thrombocytopenia

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 30
Not applicableUnknownNCT05835050
What this trial is testing

Assessment of Serum interleukin10 Level in Patients With Immune Thrombocytopenic Purpura at Sohag University Hospital

Who this might be right for
Immune Thrombocytopenic Purpura
Sohag University 50
Not applicableWithdrawnNCT01443351
What this trial is testing

Long-term Safety Study of Treatment With the Thrombopoietin Agonists Eltrombopag and Romiplostim in Patients With Immune Thrombocytopenia (ITP)

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Zealand University Hospital
Testing effectiveness (Phase 2)Study completedNCT02153060
What this trial is testing

An Investigation of Dexamethasone With Different Doses in the Management of Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Shandong University 58
Testing effectiveness (Phase 2)Study completedNCT00128882
What this trial is testing

Treatment of Idiopathic Thrombocytopenic Purpura (ITP) With Subcutaneously Administered Anti-D

Who this might be right for
Idiopathic Thrombocytopenic Purpura
University of Aarhus 45
Next Page